(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TRATAMENTO DE CÂNCER DE MAMA TRIPLO NEGATIVO QUE VISA A INIBIÇÃO DE TGF-BETA

ArquivadaInvention PatentPCT · US2019047734

Application data

Number

112021003093

Type

Invention Patent

Filing

08/22/2019

Publication

05/11/2021

PCT

US2019047734

Progress at the INPI

  1. Filing08/22/19
  2. Publication05/11/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 08/22/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 02/14/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

MERCK PATENT GMBH

DE

See this company's full portfolio

Inventors

G. L. (pessoa física)

US

I. D. (pessoa física)

US

Technical data

Priority claims

US

62/721,249 · 08/22/2018

Abstract

A presente invenção refere-se, de modo geral, a métodos para o tratamento de um paciente diagnosticado com câncer de mama triplo negativo (TNBC), que envolve identificar um paciente provável de responder ao tratamento por meio da inibição de TGF-ß visada com um agente anti-TGFß, e tratar o indivíduo com o agente anti-TGFß.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

02/14/2023

RPI 2719

Arquivamento - Art. 33 da LPI

#11.1

11/29/2022

RPI 2708

Notificação de entrada na fase nacional - PCT

#1.3

05/11/2021

RPI 2627

Alteração de dados cadastrais

#1.1

03/02/2021

RPI 2617

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.